A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer.

Accepted version
Repository URI
https://www.repository.cam.ac.uk/handle/1810/315175
Repository DOI
https://doi.org/10.17863/CAM.62283
Files
Accepted version (1.9 MB)
Type
Conference Object
Change log
Authors
Millstein, Joshua 
Budden, Timothy 
Anglesio, Michael 
Talhouk, Aline 
Beeghly-Fadiel, Alicia 
Show 5 more
Description
Keywords
32 Biomedical and Clinical Sciences, 3211 Oncology and Carcinogenesis
Journal Title
JOURNAL OF CLINICAL ONCOLOGY
Conference Name
Journal ISSN
0732-183X
1527-7755
Volume Title
36
Publisher
American Society of Clinical Oncology (ASCO)
Publisher DOI
https://doi.org/10.1200/JCO.2018.36.15_suppl.5583
Rights
All rights reserved
Sponsorship
Cancer Research Uk (None)
National Institutes of Health (NIH) (via H Lee Moffitt Cancer Center & Research Institute) (SUBAWARD # 10-15915-01-03-G2)
Congressionally Directed Medical Research Programs (CDMRP) (via (BD521555)
National Institutes of Health (NIH) (via Cedars-Sinai Medical Center) (sub award 0001331845)
H. Lee Moffitt Cancer Center & Research Institute (8604)
Collections
Cambridge University Research Outputs